Ownership history in BVF INC/IL · 12 quarters on record
This page tracks every 13F SEC filing in which BVF INC/IL reported a position in MIRUM PHARMACEUTICALS INC (MIRM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,495,290 | — | 0% | 3.98% | $118.1M | $78.99 |
| 2025 Q3 | REDUCED | 1,495,290 | -1,266,043 | -45.8% | 4.44% | $109.6M | $73.31 |
| 2025 Q2 | REDUCED | 2,761,333 | -35,180 | -1.3% | 5.02% | $140.5M | $50.89 |
| 2025 Q1 | UNCHANGED | 2,796,513 | — | 0% | 5.13% | $126.0M | $45.05 |
| 2024 Q4 | REDUCED | 2,796,513 | -279,394 | -9.1% | 3.92% | $115.6M | $41.35 |
| 2024 Q3 | REDUCED | 3,075,907 | -1,294,117 | -29.6% | 3.51% | $120.0M | $39.00 |
| 2024 Q2 | UNCHANGED | 4,370,024 | — | 0% | 4.19% | $149.4M | $34.19 |
| 2024 Q1 | UNCHANGED | 4,370,024 | — | 0% | 3.02% | $109.8M | $25.12 |
| 2023 Q4 | UNCHANGED | 4,370,024 | — | 0% | 3.23% | $129.0M | $29.52 |
| 2023 Q3 | ADDED | 4,370,024 | +3,934,088 | +902.4% | 3.72% | $138.1M | $31.60 |
As of 2025 Q4 — sorted by position size